INCLUDING AIDS RESEARCH IN BEHAVIORAL THERAPIES DEVELOPMENT PROGRAM

NIH GUIDE, Volume 23, Number 40, November 18, 1994



PA NUMBER:  PA-94-078



P.T. 34



Keywords:

  Drugs/Drug Abuse 

  AIDS 

  Health Services Delivery 



National Institute on Drug Abuse



For those investigators applying for grants under the Behavioral

Therapies Development Program, this announcement is meant to

supplement Program Announcement (PA-94-078) published in the NIH

Guide, Vol. 22, No. 26, July 15, 1994, which is still in effect and

should be consulted in conjunction with this addendum.



PURPOSE



The National Institute on Drug Abuse (NIDA) will support the study of

behavioral therapies (including counseling, psychotherapies, behavior

therapies, and skills training approaches) that will potentially have

a significant impact on reducing AIDS risk behaviors.  Therefore, the

purpose of this addendum is to encourage the incorporation of HIV

risk reduction strategies as an integral component in the development

of behavioral therapies for drug abuse and dependence treatment.

Also encouraged is the use of HIV risk measures and the provision of

HIV testing and counseling to participating subjects.  Development of

or research on HIV risk reduction interventions that can be

integrated into drug abuse treatment are potential areas of interest,

i.e., (1) incorporation of risk reduction techniques into routine

counseling or other behavioral interventions being studied; (2)

strategies to enhance motivation to change for drug abusers at risk

for HIV; (3) sexual risk reduction interventions; (4) new counseling

strategies for the provision of HIV testing and counseling and the

determination of the effective components of the counseling process;

(5) approaches for distinct drug abusing patient populations

sensitive to cultural characteristics or unique needs of specific

subgroups; (6) interventions designed to teach effective harm

reduction techniques; (7) strategies to improve HIV treatment

compliance; or (8) interventions targeting drug treatment avoiders or

treatment drop-outs.  Applicants are strongly encouraged to:  (1)

collect data on all potential risk behaviors, including, drug

administration and sexual practices; and (2) include clearly defined

measures of the effect of the therapies on AIDS risk behaviors, e.g.,

improvement of condom use skills, and decrease in needle use

frequency and high risk sexual behaviors.  Applications must be

submitted on the grant application form PHS 398 (rev. 9/91) using the

receipt dates described in the form.



AWARD CRITERIA



The following funding considerations will be applied:



o  Incorporation of HIV relevant risk reduction strategies in the

behavioral therapies or other treatments being developed and tested.

o  Inclusion of HIV risk assessment measures and discussion of the

use/provision of HIV testing and counseling.



INQUIRIES



Direct inquiries regarding programmatic issues to:



Ms. Debra Grossman or Dr. Elizabeth Rahdert

Treatment Research Branch

National Institute on Drug Abuse

5600 Fishers Lane, Room 10A-30

Rockville, MD  20857

Telephone:  (301) 443-0107

Email:  dgrossma@aoada.ssw.dhhs.gov



.

Return to 1994 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.